Mural Oncology plc
MURA
$2.09
-$0.01-0.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.88M | 8.66M | 10.49M | 8.81M | 9.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.36M | 34.38M | 35.85M | 34.10M | 34.28M |
| Operating Income | -31.36M | -34.38M | -35.85M | -34.10M | -34.28M |
| Income Before Tax | -47.98M | -33.14M | -34.27M | -31.76M | -31.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.98M | -33.14M | -34.27M | -31.76M | -31.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.98M | -33.14M | -34.27M | -31.76M | -31.56M |
| EBIT | -31.36M | -34.38M | -35.85M | -34.10M | -34.28M |
| EBITDA | -30.22M | -33.53M | -34.99M | -33.20M | -33.38M |
| EPS Basic | -2.78 | -1.93 | -2.01 | -1.87 | -1.87 |
| Normalized Basic EPS | -1.10 | -1.21 | -1.26 | -1.17 | -1.17 |
| EPS Diluted | -2.78 | -1.93 | -2.01 | -1.87 | -1.87 |
| Normalized Diluted EPS | -1.10 | -1.21 | -1.26 | -1.17 | -1.17 |
| Average Basic Shares Outstanding | 17.27M | 17.17M | 17.07M | 17.03M | 16.92M |
| Average Diluted Shares Outstanding | 17.27M | 17.17M | 17.07M | 17.03M | 16.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |